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Abstract
The process of creating new policy is frequently dependent on knowledge and study of
precedent, which in turn, helps influence future strategy. In the case of legal cannabis
state industries, there is much to be learned from policy mistakes made in how other
states managed cannabis legalization. As such, these mistakes leave gaps in policy,
which pose a threat to the rationality of the legal industry and set poor precedent for
future efforts. In turn, the goal of this paper is to identify gaps in cannabis policy and
highlight what should be seen as benchmark policy for further industry developments.
Specifically the topics touched on will include: locality referendums, problems with
access in legal markets, criminalization policy, justice for past convictions, industry
diversity, issues in cannabis taxation, cannabis concentrate/extract policy, CBD
regulation, bank access policy, uses in the opioid epidemic, health issues in cannabis
vaping, and medical cannabis insurance. Providing insight into these topics is
important, as any legalization effort undertaken should not be applauded just for its
initiation. As such, moving towards incorporating benchmark policies into the coming
legalization efforts is key, as the process of rationalizing cannabis continuously moves
forward.
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Benchmark Policies and the Rationalization of Cannabis
By: Ethan Handa

Background

In the creation and establishment of benchmark policy, much emphasis must be placed
on learning from what already exists in comparative circumstances. In the undertaking of
state-legalization of cannabis, states are frequently aware of the policy their predecessors
undertook, yet still continue to make mistakes, which are counter-intuitive to the success of the
industry. However, this also brings in the point, that the success of the cannabis industry in a
state, is not a unilateral measurement. The success of a state’s policy can be measured on
consumer satisfaction, producer revenue, state totality benefits and a host of other profiling
mechanisms. However, for certain, is that no state has created truly ideal cannabis policy,
which as a result, inherently leaves gaps in the policy that looks to govern the substances use.
Finding these gaps in policy are key to the future success of the industry and are often
portrayed by issues state-policy advocates are unaware of. As such, outlining these gaps, while
focusing on how future efforts can achieve benchmark policies are the goals of this paper. The
contribution this endeavour will undertake is finding holes in policy and suggesting
implementations, which look to rationalize cannabis through newfound benchmark policy. This
process will hopefully assist in legalization efforts of the future, which would in turn place an
emphasis on the rationality of benchmark policies in any drastic shift in status-quo.
A negative connotation and perception has surrounded cannabis for decades, which has
mostly coincided with its long standing prohibition by the federal government. There are few
studies on the short or long-term effects of cannabis use, which has halted any perception
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change science and fact can attain. This is mostly due to the significant barriers involved in
researching an illicit substance, which according to a paper by the national academy of
sciences, include: obtaining multiple forms government approval (DEA, FDA and others),
obtaining investigational new drug applications, a letter of authorization and obtaining cannabis
directly from the government to study.32 In addition, the stagnation in perceived public view is
likely due to the government’s history of suppressing research. A drugs scheduling has

significantly limited the supply for research on the substances medical (and
recreational) value, which insures that drugs viewed as higher schedule by the
government, would stay in that schedule.34 As such, this allowed the government to
continue harsh criminalization of cannabis, despite many calls for rescheduling and
study. This drawn-out process, has left few chances for findings to dispute the placement of
cannabis in the schedule 1 category of the controlled substance act, which claims cannabis to
have a high potential for abuse and no known medicinal value.33 Due to this, there has been
few ways to change perception on the substance, as little can be done to test and prove the
medicinal value or general safety of cannabis (apart from death statistics). Noticeably absent
due to these barriers to adequate research, are any studies that have been able to look at the
long term medical and recreational effects of cannabis. As such, even those who ingest
cannabis have no information on the reality of long term effects, as limits on research have
indirectly promoted the idea that using cannabis-use is irrational. Currently, the only way to
rationalize cannabis to the public, has been through state policy via the 10th amendment, which
allowed these states to legalize cannabis, despite its federal illegality.35 However, the process
of truly rationalizing cannabis goes beyond just legalizing and regulating the substance and
extends to creating the best possible policies for legalization, as current policies leave vast room
for improvement.
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History of Cannabis Criminalization
In order to move away from the negative connotation that has surrounded cannabis for
decades, a process of rationalization must occur. However, before this process can be taken
en masse, it is important to understand what has contributed to the moral framing society had
placed the substance into. This includes the negative perception created through years of
government legislation to dissuade people from using cannabis, with a special focus on it’s
criminalization for even simple possession. One of America’s first attempts to criminalize
cannabis came with the introduction of the Marijuana Tax Act of 1937, which forced purveyors
of marijuana and hemp to pay a tax or face steep fines and imprisonment.1 However, this
regulation was largely impractical, as it forced even small scale buyers to register with the
federal government, as well as the IRS, which as a result were often ignored.1 This was later
overturned in a 1969 court case, wherein judges stated that this tax policy was essentially
founded on self-incrimination.3 According to further accounts, there were multiple other reasons
for this newfound policy on cannabis, which are not too different than what is seen in the
present day. These are aptly described in a review of the legislation by drug policy expert and
Yale alum, Dr. David Musto. Musto cites racism and the perception that cannabis was useless
as the main causes for the passing of this legislation.2 Specifically, Musto remarked that there
was increasing American fear of “Mexicans”, who many claimed had perpetually caused violent
acts after using the substance.2 In regard to the perceived uselessness, it seems that this was
typically an argument based on a lack of research that came with the plant, wherein the Federal
Bureau of Narcotics felt the drug was too useless to be under their control, which led to this
ineffective policy as a result.2 In addition, Kleiman et al mentions that several high profile
arrests were made right after the laws passing in order to publicize the legislation, however this
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attitude soon ceased once fear was already incited.3 Soon after this, the Boggs Act passed in
1951, which was influential because it eliminated the marijuana tax. However, in lieu of the tax,
the Boggs Act instituted full on criminalization of cannabis, with a special focus on the
introduction of mandatory minimum sentences in the US.4 This meant that federally, any
possession of cannabis held a minimum sentence of two years in federal prison, which is a
much harsher punishment than what was found in the 1937 tax act.1,4 These minimum
sentences were later repealed, only to be put back in place years later during the Reagan

administration.7 In order to solidify his War on Drugs, President Nixon’s 1971 enacting
of the Controlled Substance Act (CSA) and 1973 creation of the Drug Enforcement
Agency (DEA) directly promoted the idea that drug use was a criminal act deserving of
harsh punishment, with diminutive chances at rehabilitation.5 This was used to incite
fear around drugs and punish many who opposed Nixon, which has been reiterated in
many 2016 reports from one of Nixon’s top presidential aides, who claimed, “the War on
Drugs was created as a political tool to fight blacks and hippies”.6 These divisive
policies looked to remove Nixon’s opposition from society by stigmatizing behavior in
order to gain political clout. To further the anti-drug rhetoric asserted by the Nixon
administration, the Reagan administration introduced the Anti-Drug Abuse Act in 1986,
which played a vast role in the racist stigma found around drugs to this day.7 The act
criminalized (freebase) crack cocaine, which was predominantly used by African
Americans, at much harsher rates than oft caucasian-used powdered cocaine.7 This
was fundamental in starting disproportionate arrest discrepancies between races, which
saw validity across all substances. In addition, mandatory minimums for cannabis and
other drugs were put into effect, which helps paint a picture of how drugs were viewed
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during this time. To further demonstrate this perception is a report by the Department of
Justice from 1987, which states: “Drug abuse has also been shown to be one of the
best indicators of serious criminal careers”.8 The report also remarks that “ $223 million
in grants (will be given) to enhance the criminal justice system's response to the drug
problem”, which clearly demonstrates the focus on criminalizing drug offenders.8
The stigma this 20th century criminalization created has lasted for decades,
which has allowed cannabis legalization to be out of the question for years. As such,
the prospect of state-wide legalization left part of the population with little understanding
of how and why this process would be undertaken. However, it seems that over time
perception of cannabis has changed.  According to Pew Research Institute, in the year
2000, 31% of the American public favored legalization.9 That number has doubled
today, as Pew saw 62% of respondents favor federal legalization in their latest public
poll.9 This potentially portrays a generational divide, which is highly based on the
propaganda perpetuated on the substance during an individual’s life, which results in
either creating stigma or openness to acceptance. This shift in perception has helped
legalize cannabis in many states, but the lasting stigma has likely contributed to many of
the policy issues we see today.
Access and Locality Referendum
Access to cannabis upon legalization is supposed to show positive externalities
like a decrease in black market sales. However, this only seems possible if the legal
market is accessible. The issue here, is that often citizens do not even get to decide if
they will have access upon legalization.12 Currently, the vast majority of op-out
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decisions are made by local elected officials, which leaves locality residents out of this
landmark process. Moreover, subtracting the people of a polis from the equation is
largely overly paternalistic. These officials also have the ability to see the will of the
people representing them through the referendum process and as a result create policy
around their decisions. All states apart from Indiana and Wyoming allow for localities to
organize and initiate public referendums on important local policies, yet municipalities
have failed to even consider this as an option.13

An example of this is seen in

Michigan, where sixty cities have decided to opt-out of recreational sales, which
effectively reduces the public’s role in these decisions, while also implicitly ignoring
potential local tax revenues that can be generate from legal sales.10 For reference,
currently in Colorado there is an average local tax on all goods of 4.6%; in addition to
this is the local excise tax on cannabis, which for example is currently 3.5% in the city of
Denver.14 As such, the near 10% projected local tax revenue taken from all potential
cannabis purchases is effectively being left on the table by local representatives. Such
financially motivated decisions should account for the will of the people, which is
something also largely missing in California post-legalization. In California, 73% of
cities and towns have banned commercial cannabis interests and sales, which has
created ‘marijuana deserts’ across the state.15 This means, that 40% of California
residents would have to drive over 60 miles in order to obtain legal cannabis, which
creates an access problem and may force consumers back into the black market,
despite the substances newfound legality.16 As of February 2019, there have been less
than five referendums surrounding legal cannabis in California, yet as previously
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mentioned, the vast majority of localities reject cultivation and sales.17 However, the
case in Massachusetts is seemingly different, as they passed Bill H.3818: An Act to
Ensure Safe Access to Marijuana.18 This act makes sure to avoid the access problems
created by the restrictive laws in California, as it mandates that cities and towns have no
fewer cannabis businesses than 20% of the amount of alcohol licenses that locality has
issued.18 However, this rule has not stopped many municipalities from outright banning
sales similar to other states. One interesting example, is the case of the Massachusetts
town of Newton, which banded together to call for a voting initiative on the town’s future
in cannabis, as council members originally wanted to outright ban sales. This
referendum saw the locality vote no to an outright ban, as well as a general limit on
commercial enterprises.19 Unfortunately, this concept of citizen choice on new,
groundbreaking policy is frequently absent, and will continue to be if locality
referendums are not taken into account in future legalization efforts. In lieu of local
referendums, a policy based on the previous statewide referendum could be effective in
addressing this lack of citizen involvement. This policy would note that if your
municipality had greater than 50% who voted in favor of legalization, you must take a
followup referendum to approve of a sales ban. This would allow a town or city to at the
very least take public opinion into account, and disallow outright bans that lack public
input. In the long-run this ability to ban legal policies at the local level could significantly
stunt the legal cannabis industry and produce the opposite effect intended with the
sales bans. As such, increased access will remain key to subtracting black market,
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criminal competition, which seems to have far greater negative externalities than legal
sales do.

 Low Access to Legal Consumption Spaces
Fundamentally found in this idea of choice, is a focus on the originality found
between areas, wherein cookie-cutter policy will fail to address individualistic concerns.
This is something realized in the cannabis legalization undertaken in Canada, where the
law is not unilateral across territories and provinces.11 These differences in law are
largely founded on distinctions in where it is legal to consume cannabis, as territories
and provinces are split over what best practice is. To further complicate things, there
are differences founded between provinces and the cities contained inside them. For
example, the province of Alberta maintains some of the most liberal laws in the nation
around public smoking, yet its biggest city, Calgary, has banned public consumption,
except in designated areas.20 The creation of designated smoking spaces is an
interesting piece of policy, as it is both stigmatizing and liberating. On one hand, this
grants smokers a place to safely use cannabis, which was never offered anywhere
throughout history. Yet, it is difficult to feel completely satisfied with being relegated
away from society to perform a legal act. This raises the question of whether the
externalities surrounding open-public consumption are truly detrimental to public health
and wellbeing. Currently in the US, no state allows for public consumption. In
Colorado, this policy brought on a stiff increase in public consumption tickets in Denver
when compared with the year prior to legalization (2013).21 Despite this, the policy in
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Colorado (and the rest of legal states) remains, that only those using cannabis on
private property have the right to do so. This creates disparities, wherein only those
wealthy enough to own their own property will have the right to consume cannabis.
Similar to the way in which an apartment complex would prohibit pets, building owners
can effectively ban consumption on their owned property. This leaves many average
citizens with no place to consume a legal substance without fear of potential
repercussions.

To rectify the lack of legal public places to consume cannabis, one would wonder
why many states fail to look towards the coffee shop model set up by the Dutch. In this
case, cannabis isn’t even legal, yet it is tolerated with a blind eye from law enforcement
if consumed on your own property or in one of the nearly 200 coffee shops throughout
the Netherlands.22 However, these coffee shops represent a communal, public place for
cannabis consumption, similar to how a traditional bar would serve alcohol throughout
the world. Since legalization in Denver, cannabis social clubs have began to pop up,
which are establishments that offer locals and tourists a place to legally consume
cannabis. However, these establishments are not common enough to actually cover
the demand of Colorado, as there are less than twenty in the entire state.23 In addition,
these places represent another financial hurdle to safe, legal consumption, as people
typically pay a membership fee to enter the space. Also important to note, is that none
of these establishments actually sell cannabis products, which directly contrasts it with
the traditional bar model. As such, these business are closer in form to someone’s
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basement, than anything resembling an upscale bar. (See Image 1) This brings out
more stigma, wherein people who want to use cannabis legally are forced away from
the norm, which also dissuades potential new consumers, due to the complexity of laws
and regulations. The absurdity of this system can easily be pointed out in a direct
comparison to alcohol, which would require someone who wants to drink to go
purchase their drink of choice, then be forced to go pay for another place to consume
this drink away from the rest of society.

However, there has recently been a shift in this anti-consumption-space
paradigm, wherein Alaska has approved on-site cannabis use for the near-future. A bill
recently signed by the Alaska Lt. Governor Kevin Myers, will allow licensed dispensaries
to apply for on-site consumption, which will begin the licensing process starting April 11,
2019.24 This bill looks to make onsite consumption at existing dispensaries the new
norm, which helps with the negative externalities found in open-air consumption, while
also reducing the time and stigma it takes to consume cannabis. In addition, this
directly addresses the gap between how homeowners vs renters can legally consume,
while also giving tourists and new consumers a more ideal experience. In Oregon,
there is also a bill (SB 639, 2019), which looks to grant licenses in a similar manner.
However, SB 639 is focused on even more than the Alaska bill, as it also looks to
legitimize other areas of the booming Oregon cannabis industry.25 The bill looks to
create what they call “consumption cafes” at already established dispensaries, while
also allowing for cannabis farm tours (similar to wine tours) and expanded cannabis
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delivery services.26 All of these do much to rationalize and legitimize the business of
cannabis, while also allowing increased access to all segments of the public population.
In other states, one would have to wonder if indoor consumption would be able to usurp
indoor smoking laws, which were passed to reduce access to secondhand tobacco
smoke. An example of this is seen in Colorado, where in 2006, the legislature issued a
statewide (tobacco) smoking ban from everywhere but private residences and
automobiles.27 Although cannabis is a completely different substance, the negative
externalities surrounding general secondhand smoke may not be enough for the
passage of on-site smoking. Overall, this is something to consider in the constant
entanglement of old law and new policy implementation, wherein new policy creation
might depend on what was set in stone in the past.

Criminalization, Clearing Convictions and Diversity in the Industry
In 2017, Pew Research Institute released a poll showing that 61% of the
American public now favor full-on cannabis legalization, which shows a steep change in
perception overtime.28 However, this perception certainly is not reflected by the laws
still surrounding the substance across the nation. This is further realized, when
analyzing marijuana possession arrest trends for 2017, which showcase that there are
increased arrests compared with years prior.29 However, when looking further into this
data, it shows that arrests for personal cannabis consumption have increased rapidly,
while arrests for manufacturing and distributions (felony or higher charges) have
decreased. This points towards a direct increase in police enforcement, as simple
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marijuana possession charges made up nearly 40% of all drug-related arrests in 2016
and 2017.30 This directly singles a change in enforcement, as police are potentially
scrambling to find ways to criminalize cannabis.

Clearly, when cannabis is legalized in a state, police enforcement should
drastically shift its focus towards criminal acts with truly negative consequences.
However, often forgotten, are those who were criminalized during decades of cannabis
prohibition, as they continue to pay with their wasted life, despite policy and law
dictating their reason for imprisonment to now be illegitimate. In late 2018, California
became the only state to see how poorly the ills of old policy have hurt those affected.
As such, Gov. Brown signed a bill, which will allow for the automatic review and
potential reduction or dismissal of low-level California cannabis charges.31 The idea is
that those caught with old policy, should not have to bare the brunt of that the rest of
their financial and professional lives. Prior to this, cities like Seattle and San Francisco,
have also passed bills, which will look to directly erase conviction records, however
California is the first legalized state to undertake this effort statewide, which looks to
overturn convictions for current offenders. In Colorado, expunging convictions is
extremely complicated, and not even something many know is available. The process
involves petitioning the court and paying fees, which might pose a barrier to
lower-income individuals who wish to expunge unjust convictions.36 Denver advocates
are calling for a wide sweeping clearance of these past convictions, which would
eliminate disparities created by differences in time and income level between the
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population. Equity would be created, in a system that wipes all past cannabis
possession charges from records, as only offering justice to those with the ability to pay
seems unfair. Additionally, what makes California’s law so different is that the
convictions are automatically reviewed, which removes the citizen from complicated
legal processes.

Another way to provide justice to those affected by poor policy is through a
system that pays vindication for ills of the past. More specifically, policy should be in
place, which provides an opportunity in the cannabis industry for those arrested using
drug war era laws. The current status quo around this actually presents the opposite
strategy being employed by the governments in legalized states. In Washington state,
regulators have set up a point system, which is used to judge if those with past crimes
can even apply for a license to work in the state’s cannabis industry.37 The system
disqualifies applicants once they reach eight total points, where it applies three points
for misdemeanors and twelve points for felony convictions from the last ten years.38
This seems unjust, as each applicant is not taken on a case-to-case basis, but rather
blanketed into a yay or nay status without further investigation into the actual crimes
they committed. This attitude towards former offenders is also showcased in a 2018 bill
that legalized industrial hemp, which is expected to be a twenty billion dollar industry by
2020.39 Industrial hemp is still defined as a “marihuana extract”, despite there being
none of the psychoactive chemical THC in it. The bill bans anyone with felony-drug
convictions from participating in the hemp industry for life. This ruling seems
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fundamentally harsh, as it also turns away people who may have talent for growing
cannabis, yet are barred due to these past convictions. Disallowing citizens from
working in an industry simply because of past (mostly unrelated) actions seems
senseless and again fails to treat past offenders as individuals, rather than a group of
irredeemable criminals.

As 80% of those in federal prisons and 60% in state prisons for drug convictions
are black or latino, these policies are making sure that the budding cannabis industry
will lack any form of diversity in the long run.40 This is something that several states are
attempting to change, with policies that look to put minorities at the forefront of the
industry, due to the tremendous oppression they faced during the war on drugs in the
past. Oakland city council has undertaken a measure dubbed, the equity permit
program, which looks to grant priority to minority communities most impacted by the war
on drugs.41 To qualify for the program, residents of Oakland must have an average
income that is 80% less than the Oakland median-about 52K, which also promotes this
program as one delivering upward mobility to a community with little options.41
However, according to the SF Chronicle, there have been significant flaws in the design
of the program, which has left many minority growers without approved space for their
legal operations.42 The plan offered non-minority companies priority, if they donate work
space for cultivation to an minority-individual granted a license. However, it seems
many of these organizations have left minority growers reeling after the companies
received their license. Changes like this demand timely accountability and enforcement
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of the policy in place, which seem to be largely absent in the implementation stage. As
such, policies will fail when they are good in ideation, yet poor in execution. Maryland
has taken a different approach, as the state only allows for medical legality currently.
However, state representatives created a plan, which will allow for additional licenses in
Maryland’s medical industry for minority owners, in order to combat the industry’s
diversity problem.43 However, this plan was only introduced after Maryland has well
established non-minority owned cannabis businesses, which dominated their medical
landscape. Additionally, a lawsuit against the plan has come into play, which states that
adding more businesses without explicit demand present, jeopardises the millions in
investments licensed business have already made. However, the lawsuit was thrown
out days later after public outcry, from activists, who planned a sit-in at one of the
companies many cannabis businesses.44 This portrays the reality of an industry, which
should have brought in minority licensing when the medical industry in Maryland was
just beginning. In future legalization and medicalization efforts, there must be some
semblance of reparations to minorities, who faced the worst of drug war punishment for
years. In lieu of this, the industry is set up to be all white-owned, which neglects the
unique history of this new commodity and allows for disparities to continue.

Cannabis Tax Issues
The tax revenue generated by cannabis legalization is often something touted as
one of the most positive externalities of cannabis legalization, even by those who
fundamentally oppose the substances consumption. These tax rates vary widely
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between legalized states, wherein there exists a divide between how much state, local
and excise tax will be levied on consumers. However, something often overlooked, is
what exactly cannabis tax funds are being spent on. Additionally, often not realized is
that cannabis tax revenue accounts for less than 2% of total state budgets in every state
that has legalized, which does not discount its potential to help, but fails to represent a
panacea that many have assumed to be present. In Colorado, recreational cannabis is
taxed in three different ways. The first, is external to the consumer, as the state’s
cannabis 15% excise tax is levied on cannabis growers selling directly to dispensaries
and distributors. The other two taxes in Colorado’s system are a general 15% rate on
retail cannabis sales, as well as a <3% local sales tax rate. 90% (or 40 million, whicher
is greater) of these funds are contributed towards a competitive public education
infrastructure improvement program, titled the B.E.S.T. program, which invests funds in
accordance with school districts matching the contributions.45,46 According to Colorado
Public Radio, this use of funding is counter to what intrigued many who voted to pass
legalization in 2012, as nothing has been invested in improving the quality of education,
teacher satisfaction or learning.46 In fact, advertisements in 2012 showcased the
message that Colorado ranked 35th in education funding in the nation, which is
something unchanged by the introduction of cannabis tax funding. The funds from the
general tax, end up in a combination of general budget funds, however the local tax can
be utilized in any way the locality feels.46,47 These local taxes have led to investments in
helping the homeless, funding scholarships and many other individualized projects.46
However, obviously absent from the nation’s first legal states tax plan, is any
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contributions toward studying the long-term effects of cannabis use. As previously
mentioned, conducting research on cannabis at the national level is an arduous
process, which has been detrimental in learning any information regarding the long-term
effects of cannabis use. However, contributing some of this tax money towards
research is completely absent from Colorado budgeting. In Washington state, there is a
similar trend, as more than 60% of the budget is contributed towards the state’s
Medicaid program, while drug research only makes up 0.1% of the entire cannabis tax
revenue budget.48 Also of note; about 8% of the budget is spent on drug treatment and
substance abuse education, which helps cover some negative externalities of cannabis
use, but again fails to invest in consideration towards long-run effects. In the 2019
legislative session, the state has begun to explore ways in which, cannabis tax revenue
can be allocated for use in opioid-treatment programs.48 In California, part of the funds
have been budgeted towards research on cannabis at UC San Diego, Center for
Medical Cannabis Research, which will receive 2 million annually for research on the
long-term health effects of cannabis.53 However, the state may have an issue coming
up with the funds for this, which will be further explored below.

Although little tax money is being diverted towards studying the potential future
harms of cannabis consumption in these states, there are greater tax problems in other
states that have legalized cannabis, beyond where the tax money is being distributed.
In Oregon, 176 cannabis business in the state owe a total of over 15 million in overdue
taxes.49 This is largely due to slim profit margins, which are a direct result of
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overproduction of cannabis products, which are only allowed to be legally sold in state,
not exported to another legal venue outside Oregon. This issue also exists, because
there is no pressure on businesses to pay in a timely manner. This is due to the fact the
Oregon Liquor Control Commission (OLCC) distributes licenses, while the department
of revenue collects cannabis taxes, which means OLCC has no power to revoke
licenses for unpaid taxes.49 Oregon has a flat tax rate of 17% on all cannabis, which is
largely less than the combined taxes found in other states.50 However, the inability to
export anything will keep sales profits lower than any projections, as in some cases
mid-grade quality cannabis is simply disposed of or given away at extremely low prices.
In California, the tax-rate on cannabis is nearly double what is found in Oregon, which
has lead to issues with sales, that has sent many consumers to the black market,
despite legality.51 In the first half of 2018, tax revenue fell over 100 million dollars short
of projections, which seems to be largely due to the near 45% aggregate tax-rate, which
exists in many counties.52 This high tax-rate is dissuading consumers from participating
in the legal market for cannabis, which has led the California state Assembly to launch
Assembly Bill 286 (the Temporary Cannabis Tax Reduction Bill).51 This bill looks to
lower the state’s cannabis excise tax from 15% to 11%, while also suspending costly
cultivation taxes till 2022.51 This will likely decrease overall tax rates by nearly 20%, but
it will be difficult to overcome a steady black market of sales, which faces no consumer
burden of tax. Keeping taxes at reasonable levels is more rational policy, because
decreasing black market cannabis use and the crime that stems from it, should largely
outweigh a focus on extremely high tax rates that dissuade consumers from legal

21

purchases. Also of note, is that California will make less than 2% of their total state
revenue off cannabis taxes, so why institute policies that act like the state will fail
without these collected funds? The main concern for future states should be passing a
reasonable tax rate, which will encourage consumers to only shop in legal venues.

Cannabis Concentrate Policy
Cannabis concentrates or extracts, which are colloquially known by many names,
but most commonly “dabs”, are something that seems to be widely misunderstood and
heavily under-regulated in legal states.54 (See Image 2) In recent years, news outlets
have showcased this lack of understanding, by claiming concentrates are ‘dangerous’,
‘equal to 15-20 joints of weed at once’ and ‘super-high potency’.55,56 These reactions
are exaggerated, however, the substance seems to be no more dangerous than regular
cannabis if appropriate dosages are followed.54 One of the main dangers currently
seems to be in regard to the production of concentrates, which often involves a
butane-based extraction process that has caused explosions and fires across the
nation.57 This poses a health threat in this new industry, as Politico notes that states
offer no health or safety guidance towards concentrate producers. Additionally, the
national institute for occupational safety and health is unable to act in any state-based
legalization efforts, which means there have been no standard hazard evaluations in
this industry space.57 Also of note, is that fire and safety personnel will likely have never
seen a butane hash oil fire, which is another cause for concern. These vast

22

impediments to safe production require a focus on increased guidelines or mandatory
licensing, as currently these setups are conducive to danger and injury.

As of now, many states have laws that limit the amount of concentrate that can
be legally purchased in a single transaction to a certain number of grams (5gs in most
states, 8gs in Colorado).98 However, these laws are difficult to enforce, as a consumer
can just travel to another store and purchase the limit again. Passing policy, which
takes note of this potential loophole, while also taking note of the potency disparity
seems key. As such, apart from the potential dangers that can occur in the production
of cannabis concentrates, is the unstable place these products hold alongside regular
cannabis flowers in the industry. In the case of the American liquor industry, hard liquor
is taxed at higher rates than beer and wine, while also having greater general
restrictions from state to state. For example, in Washington state, the excise tax per
gallon of hard liquor is more than 50x the rate, which beer is taxed at per gallon in the
state.58 Another example of this differentiation, is seen in New York state, which
mandates separate stores for the sale of liquor and the sales of beer and wine, as the
state looks to draw the distinction between the substances.59 With reference to that, it
makes little sense that extremely high strength cannabis concentrates are treated and
taxed the same in states where they are legal. This seems to be a hole in every state’s
legislation, as there is much misunderstanding around these substances. Although
cannabis concentrates do not have the same track record of over-intoxication and death
that hard liquor does, it makes fundamental sense for more regulation to be put in place
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around the substances. This is because, similar to hard liquor, there is inherently
greater risk that comes with using cannabis concentrates, when compared with
cannabis flower, especially to new, inexperienced consumers An increase in regulation
of these high THC extracts seems essential, as a lack of regulations contributed to a
doubling of cannabis related hospital visits in Colorado after their first year of
legalization.60 The vast majority of these cases were a direct result of overconsumption,
which similar to alcohol, will leave users feeling out of control or sickly. As such, an
increase in taxes and regulation for high strength extracts and products is necessary to
rationalizing cannabis concentrates and protect general public health.

CBD Regulation
Cannabis is comprised of over a hundred different cannabinoids, which are the
chemicals in the plant that act on the brain.61 The chemical that gives off the high
found in cannabis is tetrahydrocannabinol (THC), which makes it the most noted
chemical found within the plant. However, with the introduction of the aforementioned
2018 hemp-farm bill, the federal government effectively federally legalized the use of
the hemp-derived, non-psychoactive cannabinoid: cannabidiol (CBD).39 CBD doesn’t
possess the ‘high’ that THC does, rather, CBD consumers are after a supposed myriad
of (unverified) health benefits. According to Harvard Medicine, the only condition with
lengthy, valid research on the effectiveness of the CBD are intense childhood seizures,
which seem to cease with CBDs medicinal use. Many also claim CBD can assist with
chronic pain, depression, anxiety and other conditions, all of which have little published
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research to substantiate the claims.63 Despite issues with validity, CBD has seen
projections that show it as a 16 Billion dollar industry by 2025, which is largely
predicated on it’s introduction to many traditional retail businesses throughout the US.62
CBD has appeared in many different varieties, but mostly as a food, drink or plant form.
The plant form has been under the harshest scrutiny, because it looks nearly identical to
THC cannabis, despite having under the illegal limit (0.3%) THC. (See Image 3) This
has led to numerous confusion-based, unjust arrests in states where THC cannabis still
remains illegal to possess.64,65,66 However, there is much truth to the idea that CBD has
allowed cannabis as a whole to gain greater acceptance, a fact that is signaled by its
presence on the counter of large corporate pharmacies like CVS and Walgreens.57 This
normalization of a cannabinoid is important, as it demonstrates that the potential
medical benefits of cannabis have the ability to outweigh harms even in the most
corporate of spaces. CBDs federally legal status, should also make room for the
introduction of new research on the chemical’s clinical benefits. This is important,
because without fact to substantiate these claims, the widespread use of CBD may be
unwarranted or placebo. So, while CBD is now mainstream, the data to back this
popularity up is largely absent at current.

Despite the vast market for CBD products, there is reason for concern over the
actual contents of the product consumers are receiving. The unregulated market for
CBD directly contrasts with the strict lab testing THC products must go through in all
legal states. This leaves consumers to trust a brand they have likely never heard of, due
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to a failure to confirm the true contents. This lack of regulation has led New York City
Department of Health to ban the sale of food and drinks that contain CBD in NYC, as
the uncertainty surrounding the products seem to be the issue.68 This stance has also
recently been echoed by the FDA, who wishes to further evaluate the safety of CBD in
food and drink products.69 Despite this, CBD products continue to be sold around the
country, with consumers putting all their trust in the product’s producers. The contents
of CBD products is a dual sided issue, wherein the first issue is in the actual amount of
CBD in a product, which is difficult to verify without lab testing. This is especially
apparent because CBD does not have any noticeable mental or physical effects like
THC cannabis does. This can allow for products to be marketed and sold as CBD
containing, yet contain little to no CBD.70 The other side of this issue is that there is also
potential for extraneous, and potentially dangerous substances to be found in legal CBD
products. A CBD corporation called Diamond CBD has had products that test positive
for synthetic cannabinoids, dextromethorphan and high concentrations of melatonin,
despite products being labeled as only CBD.71 The company is deceiving people in an
unregulated market, which can be dangerous to consumer health. These dangers to
public health of consumers are why all CBD products should be lab-tested and
regulated. This seems to largely be a case of late action from the FDA, based on their
miscalculation of CBDs popularity among the general public. However, this regulation
might be less important than legitimate studies, which prove CBD to be an effective
treatment, as the FDA has already set limits on the products advertising.72 These look

26

to limit false claims of CBDs medical abilities, which many producers have touted in the
absence of regulation.

Bank Access for Cannabis Businesses
Despite the success many states have had in invoking the 10th amendment to
legalize cannabis in their respective states, something that always must be considered,
is the federally illegal status the substance still holds. This is especially important in
regard to how legitimate cannabis business are able to manage their funds. In 2014,
the Obama administration Treasury Department issued a memo to federal banks,
saying that legitimate, legal-state cannabis businesses should be no issue at federal
banks, as they would simply require slightly more oversight and reporting.73 Despite this
proclamation, large federal banks have shown an unwillingness to work with legal
cannabis businesses, which is a direct result of conflicting state and federal law that
institutions feel could lead them to federal money laundering charges. This has placed
the burden on smaller credit unions and independent banks, who often do not have the
same credibility, perks and wide accessibility found in banking with a federal chain.74 As
such, this has left legitimate businesses with few options to deposit large sums of cash,
which is a direct detriment to their safety and financial security. On the state side, this
lack of known income can also place stress on tax collection, wherein the true amount
of sales can be withheld from the state. In response to these concerns, the US House
Financial Services Committee has advanced a federal banking bill to the full house at
the end of March, 2019.75 This federal measure would look to codify concerns that
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banks have with businesses, which are effectively viewed as federally illegal. The bill is
expected to have moderate bipartisan support, but regardless will easily pass the
Democrat controlled House of Representatives. However, the bill could run into some
trouble in the US Senate, where Republicans have control. This is already apparent, as
some of the Republicans in the preliminary Financial Services committee have already
opposed the bill.75 As such, this seems like a long-term fight, which if won, would help
legitimize cannabis to the public and add greater safety to the financial side of the
cannabis industry. However, at current, cannabis finances sits in a grey area between
federal and state bureaucracy, which does much to subtract from the substances
rationality. Which is furthered, when legitimate cannabis businesses are still treated as
criminal at the federal level.

Potential uses for Cannabis to combat the Opioid Epidemic
With the opioid epidemic causing a myriad of issues across the nation, some
states have pursued medical cannabis as a substitute for opioid prescriptions. Most
notably, this effort has been undertaken in Illinois, where the state passed the
Alternatives to Opioids Act of 2018, which includes the opioid alternative pilot program.76
This program allows anyone with an opioid prescription to be offered a medical
cannabis license instead. Additionally, this program allows for some cases of pain to be
added to the accepted conditions list for medical cannabis.77 The New York State
Department of Health has a similar plan, which allows the substitution of cannabis for
prescribed opioids. However, interestingly, the regulations also allow opioid users in
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treatment, to use cannabis in conjunction with buprenorphine or other opioid-abuse
treatments.78 These policies have been met with criticism from physicians and scholars,
who say that fundamentally, cannabis does not have the same ability to treat
neuropathic pain that opioids do (79,80). Humphreys and Saitz suggest, that there is
little to no evidence in scientific studies, but this seems to be largely due to the fact
cannabis research has been widely restricted for decades.32,79 However, it seems they
are missing the point of these pieces of legislation, which is to limit new cases of opioid
abuse by halting potential addiction before it can start. Additionally, the bills still allows
citizens to seek opioid prescriptions if they find cannabis inadequate for their pain
management. Despite the lack of validity in research into the true effects of cannabis
on pain, Campbell et al had some notes stating that cannabis has potential to at least
change someone’s perception of the pain they are feeling, even if they are still
experiencing that pain in actuality.80 This is something that certainly requires more
research, which should happen now that cannabis research is less restrictive than ever.
Another reason there could be some benefit to these policies, is found Bachhuber et al,
which showcases that opioid overdose rates are largely down in states that legalized
medical cannabis.81 Specifically, states that legalized medical cannabis by the time of
the studies publishing saw a combined 25% less opioid-overdose rate on average,
when compared with non-legal medical states.81 This shows some level of promise,
which if further studied highlights cannabis as a promising ally in the fight to combat the
opioid epidemic. However, only time will reveal if cannabis is an adequate substitute for
opioids or just part of an interesting, yet inaccurate proposal.
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Serious Health Problems in Cannabis Vaping
Some project the American nicotine vape industry to reach nearly 45 billion in
size by 2023, however a significant impediment to this may lie in how the FDA chooses
to regulate these products.82 This late response by the FDA is a direct result of
heightened consumption rates by teen vaping, which had increased 80% among high
school students.83 As a result, the FDA has considered a number of options to fix this
issue; including: banning flavors that appeal to use, banning social media advertising
and raising taxes.84 This increased scrutiny around the nicotine vape industry has
showcased the direct issues found in these products. However there has been very little
of this attention put towards the newly popular, cannabis vape cartridges (CVC). CVC
may sound like a safer alternative to smoking cannabis, however both the legal and
illegal industries have faced tremendous concerns. In the legal industry in California,
CVC have consistently tested positive for pesticides, which are commonly found in
agriculture, but lead to toxic emissions when heated. This is especially concerning, as
the oil used in CVC is concentrated cannabis, which as a result might hold concentrated
amounts of pesticides.85 This places a spotlight on the safety concerns that come with
these products, which is something echoed in Alzghari et al, which found that 80% of
cannabis concentrates they tested contained elevated levels of pesticides, which were
labeled as unsafe for human consumption.86 Another concern in the California market,
is the false advertising discovered by the state’s mandatory lab testing, which found the
majority of cannabis cartridges to contain lower percentages of THC than advertised.86
This is of special note, as some California cannabis testing labs have been caught
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falsifying the facts and figures of their tests.87,88 In addition, other lab tests have
identified toxic metals in the design of the cartridges, which potentially release lead into
vapor when heated.89 This issue requires validity to the testing of cannabis vape
cartridges, as these health hazards subtract from the validity and safety of the legal
industry. As such, there should be great concern, when a legal industry is potentially
peddling unsafe products to consumers.

In non-legal states, there has been a separate movement, which has black
market consumers in fear. This is because cartridges in illegal states can be mass
produced and sold without any testing of the cartridges actual contents, which means
that there is no validity to the actual chemicals (and potential toxins) a consumer is
inhaling. However, even more concerning is the abundant presence of knockoff
packaging, which looks to mimic legitimate, legal-state cannabis vape cartridge
brands.90 This packaging directly mirrors the legal product and is widely available from
Chinese wholesalers, who have perfected the copy cartridge designs. This has led to
an unregulated black market, where the end-user has no information on a products
validity, but may be unaware of these issues.90 Another concern in this space, is similar
to the nicotine vape industry, in that certain packaging designs can lead to youth use.
This is because some other forms of Chinese-manufactured packaging is not a brand,
but showcases Nintendo’s Mario characters, naming them “Mario Carts” (short for
cartridges).91,92 (See Image 4) There are also other cartridges dubbed “Exotic Carts”,
which try to draw in consumers with a variety of supposed dessert flavors and bright
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colors.93 (See Image 5) This is extremely concerning, as it can draw in youth, while
there are further flags raised by the potential mystery contents of the cartridges
themselves. Enforcement of these cartridges has to be a priority for law enforcement
and public health experts, as the dissemination of such dangerous products must be
noted. As for consumers, it seems that any black-market cannabis cartridge should be
considered unsafe, as the user has no possible way to test for the actual contents of the
product they are consuming.

Medical Cannabis Insurance
In cases where a physician prescribes medicine to a patient, the patient’s
insurance will typically cover a percentage of, if not the entire cost of the medication.
This is one of the many reasons that patients invest in their health insurance, because
some treatments can be excessively expensive to pay for out-of-pocket. However, left
out of any form of American health insurance coverage is medical cannabis, which is
barely even mentioned by insurers. One of America’s top health insurers, Cigna, offers
no official opinion on medical cannabis on their website, however they do somewhat try
to dissuade patients in legal-medical states from seeking out the treatment by saying
medical users might be federally prosecuted at any time.94 This seems like a complete
exaggeration, as even if the federal government was to prosecute anyone for medical
cannabis, it would be the states themselves who invoked the tenth amendment to pass
the policy. Furthermore, it seems that large insurers will never cover medical cannabis
in America due to the aforementioned place it holds in schedule one of the controlled
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substances act.33 Additionally, a lack of FDA approval means that the substance would
never see coverage by government insurance schemes, as the government themselves
view cannabis as fundamentally unsafe for medical use.95 There is also room for
discussion on how medicaid plans could potentially cover state medical cannabis
prescriptions, although this would likely lead to intervention by the federal government.
The opioid pilot programs previously mentioned in New York and Illinois seem the
proper place to supply this logic, as the plan allows for coverage of opioids, yet if they
painkillers are replaced with cannabis, the fees immediately become out of pocket
costs.76,77 This showcases the idea that medical cannabis is different, in that the
treatment is perceived as a luxury for patient-consumers, with little reason to have
coverage for it. This again seems to be an issue, due to a lack of lengthy, accurate
research on the medical benefits of cannabis. However, of note here, is that states do
not impose the same tax rates on medical cannabis, as they do with recreational, which
offers some break to consumers with medical needs. To further question this
medicalization process, one would wonder why medical cannabis patients need to pay a
yearly license fee in addition to the steep out of pocket costs. However, it seems that
the amount paid yearly for a medical cannabis card varies heavily by state, where some
have no fees, yet some charge hundreds.97 An interesting proposal could see medical
cannabis licensing fees potentially covered through state-raised cannabis tax funds,
which would be a good way to legitimize cannabis medicalization.
In Canada, one of the nation's largest health insurers, Sun Life Assurance Co,
has moved to cover medical cannabis for the patients they insure.96 The insurer has
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agreed to cover the treatment as a result of much consumer feedback, wherein they
have offered $1.5K-6K coverage per person, per year. However, the conditions they
cover are extremely limited and very severe, which leaves little space for non-life
threatening conditions to receive covered treatment.96 Regardless of that, this move by
Sun Life Assurance Co is monumental, as it helps invoke the idea that cannabis is a
legitimate, rational product, which can assist with medical issues. In the US though, it
seems unlikely that any insurer will look to provide coverage for medical cannabis, until
it is approved by the FDA or taken off the controlled substances list. As such, some
focus should be placed on the legitimacy of medical cannabis as a treatment, which in
the long-run might change perceptions of what should and should not be covered in
medical care.

In Closing
Overall, the point needs to be made, that policy has not reached perfection in the
governing of other substances either, be it legal or illicit. In the case of alcohol, each
day 29 people die on average from drunk driving accidents, yet there is has been no
major reform in this policy area for nearly twenty years.104,105 Additionally, excessive
alcohol consumption is linked with a myriad of negative health effects, which again has
seen little true attention from policymakers.107,108 Some of this is likely due to public
perception, as alcohol-use has been perceived as rational for centuries. As such, this
denotes the difficulty in changing policy around such a longstanding state of affairs. On
the illicit side of substances, there is now a movement in Oregon and Colorado to
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legalize psilocybin mushrooms for therapeutic use, yet this is difficult to see, when
cannabis legalization has faced so many issues.106 Similar to cannabis, psilocybin
mushrooms have seen very little medical research, which is one of main reasons for
their long-term prohibition. However, similar to cannabis rationalization, changes can
slowly take place, which will allow for the potential for legitimate mushroom use to enter
society. Despite this, this legalization effort will likely be even more restrictive than
cannabis, which in the end saw uneven control efforts, despite overwhelming public
support for cannabis legalization.9 Both of these cases signal, that each substance
needs its own, individual policy around it. Looking for comparisons between substances
can be useful, but individual perception will play a vast role in real policymaking.

Overall, it seems most of these benchmark cannabis policies are only relevant to
cannabis legalization efforts of the future. As such, the originality of the history and
perception of cannabis, place it in a policy category on its own. However, an increased
focus on how to correct errors of the past, while looking towards the future, seems key
to continued rationalization of cannabis and the policies that govern it. With all of these
insights in mind, it would seem as if cannabis legalization efforts thus far have left much
to be desired. However, there needs to be some emphasis placed on the uniqueness
that effectively comes with this vast shift in policy, in that to this point, there has been
little precedent to act on. Moreover, it seems that any cannabis legalization effort
undertaken by states is applauded, simply because any sort of reform in this space is
long overdue. However, as the US progresses towards further state legalization efforts
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of cannabis, a learning from these errors of the past will only introduce improved
policies. As such, taking all of these policy area recommendations into account seems
crucial to truly creating benchmark policy, which rationalizes cannabis to society.

Images

36

Image 199

Image 2100

37

Image 3101

Image 4102

38

Image 5103

References
1. US Legal, Inc. (n.d.). Marijuana Tax Act Law and Legal Definition. Retrieved from

2.
3.
4.
5.
6.

https://definitions.uslegal.com/m/marijuana-tax-act /
Musto, D. F. (1972, February 01). The Marihuana Tax Act of 1937. Retrieved from
https://jamanetwork.com/journals/jamapsychiatry/fullarticle/490581
Kleiman, M. A., & Hawdon, J. E. (n.d.). Marihuana Tax Act (1937). Retrieved from
http://sk.sagepub.com/reference/drugpolicy/n213.xml
Marijuana Timeline. (n.d.). Retrieved from
https://www.pbs.org/wgbh/pages/frontline/shows/dope/etc/cron.html
Timeline: America's War on Drugs. (2007, April 02). Retrieved from
https://www.npr.org/templates/story/story.php?storyId=9252490
LoBianco, T. (2016, March 24). Report: Nixon's war on drugs targeted black people.
Retrieved from

39

https://www.cnn.com/2016/03/23/politics/john-ehrlichman-richard-nixon-drug-war-black
s-hippie/index.html
7. Thirty Years Of America's Drug War: A chronology. (n.d.). Retrieved from
https://www.pbs.org/wgbh/pages/frontline/shows/drugs/cron/
8. Graham, M. G. (1987). Controlling Drug Abuse and Crime: A Research Update.
Retrieved from
https://www.ncjrs.gov/App/abstractdb/AbstractDBDetails.aspx?id=104865
9. Hartig, H., Geiger, A., Hartig, H., & Geiger, A. (2018, October 08). 62% of Americans
favor legalizing marijuana. Retrieved from
http://www.pewresearch.org/fact-tank/2018/10/08/americans-support-marijuana-legalizat
ion/
10. Jordan, J. (2019, April 16). These 60 Michigan cities have opted out of recreational
marijuana sales. Retrieved from
https://www.metrotimes.com/news-hits/archives/2019/01/02/these-60-michigan-cities-ha
ve-opted-out-of-recreational-marijuana-sales
11. Gaughan, J. (2019, January 15). Here's How Cannabis Legalization Differs From
Province To Province In Canada. Retrieved from
https://www.narcity.com/news/heres-how-cannabis-legalization-will-be-different-from-pr
ovince-to-province-in-canada
12. Lovett, K., & Lovett, K. (2019, January 15). Cuomo would prohibit sale of pot to anyone
younger than 21, allow localities against marijuana legalization to opt out. Retrieved from
https://www.nydailynews.com/news/politics/ny-pol-cuomo-pot-legalization-20190114-st
ory.html
13. Laws governing local ballot measures. (n.d.). Retrieved from
https://ballotpedia.org/Laws_governing_local_ballot_measures
14. Scarboro, M. (2018, March 26). How High are Marijuana Taxes in Your State? Retrieved
from https://taxfoundation.org/marijuana-taxes-state/
15. Replogle, J. (2017, December 19). As California Embraces Legal Marijuana, Many Cities
and Counties Say 'No'. Retrieved from
https://www.kqed.org/news/11637917/as-california-embraces-legal-marijuana-many-citie
s-and-counties-say-no
16. Branan, B., & Levine, N. (2018, March 25). Weed is legal. But this map shows just how
much of California is a 'pot desert'. Retrieved from
https://www.sacbee.com/news/state/california/california-weed/article205524479.html
17. Local marijuana on the ballot. (n.d.). Retrieved from
https://ballotpedia.org/Local_marijuana_on_the_ballot
18. An Act to Ensure Safe Access to Marijuana Bill H.3818 190th (2017 - 2018). (n.d.).
Retrieved from https://malegislature.gov/Bills/190/H3818

40

19. Edelson, J. (2018, November 06). Newton voters reject ballot questions that would have
limited marijuana shops - The Boston Globe. Retrieved from
https://www.bostonglobe.com/news/marijuana/2018/11/06/newton-voters-weighing-recre
ational-marijuana-questions/rb6ArOkxN8X1jJczgQBjKI/story.html
20. Elliott, J. K. (2018, October 17). Cannabis IQ: A visitor's guide to smoking legal
marijuana in Canada. Retrieved from
https://globalnews.ca/news/4438410/canada-marijuana-tourism-pot-visitor-guide/
21. Markus, B. (2014, November 14). Marijuana public consumption tickets up 471 percent
in Denver. Retrieved from
https://www.cpr.org/news/story/marijuana-public-consumption-tickets-471-percent-denv
er
22. Haines, G. (2017, February 21). Everything you need to know about marijuana smoking
in the Netherlands. Retrieved from
https://www.telegraph.co.uk/travel/destinations/europe/netherlands/amsterdam/articles/ev
erything-you-need-to-know-about-smoking-marijuana-in-the-netherlands/
23. Marijuana Social Lounges. (n.d.). Retrieved from
https://www.coloradopotguide.com/what-to-do/marijuana-social-lounges/
24. Dickson, E. (2019, March 13). Alaska Approves On-Site Marijuana Use. Retrieved from
https://www.rollingstone.com/culture/culture-news/alaska-weed-consumption-on-site-pot
-bar-807817/
25. Roberts, C. (2018, August 26). Push To Legalize Marijuana Consumption Spaces In
Oregon Kicks Off. Retrieved from
https://www.marijuanamoment.net/push-to-legalize-marijuana-consumption-spaces-in-or
egon-kicks-off/
26. Norml. (2019, February 01). Oregon: Cannabis Social Consumption Bill SB 639 Is About
Civil Rights. Retrieved from
https://blog.norml.org/2019/01/31/cannabis-social-consumption-bill-sb-639-about-civil-ri
ghts/
27. State of Colorado Clean Indoor Air Act. (n.d.). Retrieved from
https://www.colorado.gov/pacific/sites/default/files/Indoor air LE Key Points_0.pdf
28. U.S. public opinion on legalizing marijuana, 1969-2017. (n.d.). Retrieved from
https://www.pewresearch.org/fact-tank/2018/10/08/americans-support-marijuana-legaliza
tion/ft_18-01-05_marijuana_line_update/
29. Angell, T. (2018, September 24). Marijuana Arrests Are Increasing Despite Legalization,
New FBI Data Shows. Retrieved from
https://www.forbes.com/sites/tomangell/2018/09/24/marijuana-arrests-are-increasing-des
pite-legalization-new-fbi-data-shows/#7326269f4c4b

41

30. 2016 Crime in the United States: Table 18. (2017, September 07). Retrieved from
https://ucr.fbi.gov/crime-in-the-u.s/2016/crime-in-the-u.s.-2016/topic-pages/tables/table-1
8
31. Norwood, C. (2018, October 1). California's New Marijuana Law Is a First But Likely
Not the Last. Retrieved from
https://www.governing.com/topics/public-justice-safety/gov-california-marijuana-crimina
l-record-state.html?utm_term=California's New Marijuana Law Is a First But Likely Not
the Last&utm_campaign=Distracted by Data&utm_content=email&utm_source=Act-On
Software&utm_medium=email
32. Challenges and Barriers in Conducting Cannabis Research. (2017, January 12). Retrieved
from https://www.ncbi.nlm.nih.gov/books/NBK425757/
33. Drug Scheduling. (n.d.). Retrieved from https://www.dea.gov/drug-scheduling
34. Lopez, G. (2016, August 11). The federal government won't change marijuana's
"schedule." Here's what that means. Retrieved from
https://www.vox.com/2014/9/25/6842187/drug-schedule-list-marijuana
35. The 10th Amendment of the U.S. Constitution. (n.d.). Retrieved from
https://constitutioncenter.org/interactive-constitution/amendments/amendment-x
36. Colorado should wipe low-level marijuana convictions clean. (2018, December 05).
Retrieved from
https://www.denverpost.com/2018/12/04/remove-low-level-marijuana-convictions/
37. Rough, L. (2017, June 09). Can You Get a Cannabis Business License if You're a
Convicted Felon? Retrieved from
https://www.leafly.com/news/industry/can-convicted-felons-get-a-cannabis-business-lice
nse
38. Marijuana Licensing: Criminal History Record Check. (n.d.). Retrieved from
https://lcb.wa.gov/mjlicense/criminal_history_check
39. Avins, J. (2018, December 15). Proposed hemp regulations continue the racist legacy of
the US war on drugs. Retrieved from
https://qz.com/1475224/proposed-hemp-regulations-continue-the-racist-legacy-of-the-uswar-on-drugs/
40. Race and the Drug War. (n.d.). Retrieved from
http://www.drugpolicy.org/issues/race-and-drug-war
41. Fox, H. (2018, June 25). Can Oakland Help Solve the Weed Industry's Diversity
Problem? Retrieved from
https://www.rollingstone.com/culture/culture-features/can-oakland-help-solve-the-weed-i
ndustrys-diversity-problem-196047/
42. Taylor, O. R. (2018, July 15). Oakland's marijuana equity program is hurting those it was
supposed to help. Retrieved from

42

https://www.sfchronicle.com/news/article/Oakland-s-marijuana-equity-program-is-hurtin
g-13077077.php
43. Dresser, M. (2019, April 07). Maryland lawmakers reach deal on medical marijuana
licenses, making more minority owners likely. Retrieved from
https://www.baltimoresun.com/news/maryland/politics/bs-md-medical-marijuana-deal-20
180407-story.html
44. Donovan, D. (2019, April 07). Baltimore County cannabis grower sues to stop Maryland
from awarding new licenses that could improve diversity. Retrieved from
https://www.baltimoresun.com/news/maryland/politics/bs-md-cannabis-growers-lawsuit20190326-story.html
45. Marijuana Tax Revenue and Education Infograph. (n.d.). Retrieved from
https://www.cde.state.co.us/communications/marijuana-fact-sheet-marijuana-tax-revenue
-for-education-after-july-2018
46. Brundin, J. (2018, October 22). Do Marijuana Taxes Go To Schools? Yes, But Probably
Not In The Way You Think They Do. Retrieved from
https://www.cpr.org/news/story/do-marijuana-taxes-go-to-schools-yes-but-probably-not-i
n-the-way-you-think-they-do
47. Roberts, M. (2018, September 18). Here's Where Your Colorado Marijuana Tax Dollars
Go. Retrieved from
https://www.westword.com/news/heres-where-your-colorado-marijuana-tax-dollars-go-1
0214271
48. Whittenberg, J. (2018, August 08). Where does Washington's marijuana tax money go?
Retrieved from
https://www.king5.com/article/news/local/where-does-washingtons-marijuana-tax-money
-go/281-581833195
49. Andrews, R. (n.d.). 176 Oregon cannabis businesses owe Oregon $15.7M in overdue
taxes. Retrieved from
https://kval.com/news/local/176-oregon-cannabis-businesses-owe-oregon-157m-in-overd
ue-taxes
50. Recreational Marijuana FAQs. (n.d.). Retrieved from
https://www.oregon.gov/olcc/marijuana/Pages/FAQs-Taxes.aspx
51. Daniels, J. (2019, January 29). California proposes slashing pot taxes to help regulated
industry compete with black market. Retrieved from
https://www.cnbc.com/2019/01/28/calif-bill-introduced-to-slash-pot-taxes-as-legal-indust
ry-struggles.html
52. Williams, S. (2017, November 12). California Could Tax the Daylights out of Marijuana
Consumers. Retrieved from
https://www.fool.com/investing/2017/11/12/california-could-tax-the-daylights-out-of-mar
ijuan.aspx
43

53. Williams, S. (2016, October 15). Here's How California Would Spend Its Expected $1
Billion in Marijuana Tax Revenue. Retrieved from
https://www.fool.com/investing/2016/10/15/heres-how-california-would-spend-its-expect
ed-1-bi.aspx
54. Al-Zouabi, I., Stogner, J. M., Miller, B. L., & Lane, E. S. (2018, November 02). Butane
hash oil and dabbing: Insights into use, amateur production techniques, and potential
harm mitigation. Retrieved from
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220730/
55. Dangerous new marijuana product looks like lip balm, packs big kick. (n.d.). Retrieved
from
https://www.foxnews.com/health/dangerous-new-marijuana-product-looks-like-lip-balmpacks-big-kick
56. Jackman, T. (2015, December 23). Shatter, a super-high-potency marijuana, is appearing
on the East Coast. Retrieved from
https://www.washingtonpost.com/local/public-safety/shatter-super-high-potency-marijua
na-now-appearing-on-east-coast/2015/12/23/e09dfde4-a8fa-11e5-bff5-905b92f5f94b_sto
ry.html?utm_term=.c3cc8b79325d
57. Rainey, R., Owermohle, S., & Higdon, J. (2019, February 18). New problem for legal
weed: Exploding pot factories. Retrieved from
https://www.politico.com/story/2019/02/18/marijuana-factories-explosions-safety-issues1155850
58. State Alcohol Excise Taxes. (2018, March 13). Retrieved from
https://www.taxpolicycenter.org/statistics/state-alcohol-excise-taxes
59. New York Liquor Laws. (n.d.). Retrieved from
https://www.stateliquorlaws.com/state/NY
60. Blake, A. (2016, April 18). Colorado hospitals and treatment centers say
marijuana-related cases have spiked. Retrieved from
https://www.washingtontimes.com/news/2016/apr/18/marijuana-related-hospitalizationsspike-in-colora/
61. Atakan, Z. (2012, December). Cannabis, a complex plant: Different compounds and
different effects on individuals. Retrieved from
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3736954/
62. Dorbian, I. (2019, March 12). CBD Market Could Pull In $16 Billion By 2025, Says
Study. Retrieved from
https://www.forbes.com/sites/irisdorbian/2019/03/12/cbd-market-could-pull-in-16-bln-by
-2025-says-study/#3db60bc83efd
63. Grinspoon, P. (2018, August 24). Cannabidiol (CBD) - what we know and what we don't.
Retrieved from

44

https://www.health.harvard.edu/blog/cannabidiol-cbd-what-we-know-and-what-we-dont2018082414476
64. Interstate hemp commerce under fire despite Farm Bill assurances. (2019, February 05).
Retrieved from
https://hempindustrydaily.com/interstate-hemp-commerce-under-fire-despite-farm-bill-as
surances/
65. Whitmire, L. (2019, January 06). Ohio man facing two felony possession of drug charges
for cannabidiol oil. Retrieved from
https://www.mansfieldnewsjournal.com/story/news/2019/01/06/ohio-man-facing-two-fel
ony-possession-drug-charges-cbd-oil/2466832002/
66. Etters, K. (2018, November 21). Tallahassee CBD business raided, thousands of dollars
in hemp seized. Retrieved from
https://www.tallahassee.com/story/news/2018/11/20/tallahassee-cbd-dispensary-raided-th
ousands-dollars-hemp-seized/2068011002/
67. Pitofsky, M. (2019, April 05). CBD products are popping up in stores near you. Here's
what you need to know about them. Retrieved from
https://www.usatoday.com/story/news/health/2019/04/04/cbd-what-you-need-know-cann
abis-products/3366442002/
68. Gold, M. (2019, February 05). New York City Cracks Down on CBD Edibles, Saying the
Cannabis Derivative Is Unsafe. Retrieved from
https://www.nytimes.com/2019/02/05/nyregion/cbd-food-nyc-restaurants.html
69. Sander, J. (2019, April 05). FDA Schedules Hearing on CBD-Infused Food and Drinks.
Retrieved from
https://www.marijuanatimes.org/fda-schedules-hearing-on-cbd-infused-food-and-drinks/
70. Puri, S. (2019, April 11). 'Patients Are Being Duped': What's Inside Some CBD Products.
Retrieved from
https://www.nbcconnecticut.com/investigations/Patients-are-Being-Duped-Whats-InsideSome-CBD-oil-Products-506011161.html
71. Love, S. (2018, November 30). CBD Vape Liquid Contains Dangerous Ingredients.
Retrieved from
https://tonic.vice.com/en_us/article/j5zdd8/cbd-vape-liquid-contains-dangerous-ingredien
ts
72. Keshner, A. (2019, April 07). FDA warns companies to stop making 'unsubstantiated'
claims about CBD curing cancer and Alzheimer's. Retrieved from
https://www.marketwatch.com/story/government-warns-companies-to-stop-making-unsu
bstantiated-claims-about-cbd-2019-04-04
73. Angell, T. (2018, November 29). More Banks Welcome Marijuana Business Accounts,
New Federal Report Shows. Retrieved from

45

https://www.marijuanamoment.net/more-banks-welcome-marijuana-business-accounts-n
ew-federal-report-shows/
74. Zhang, M. (2017, December 31). Florida's Medical Marijuana Industry Is Losing Its
Bank, But Others Are Stepping In. Retrieved from
https://www.forbes.com/sites/monazhang/2017/12/31/floridas-medical-marijuana-industr
y-is-losing-its-bank-but-others-are-stepping-in/#4b65389f4470
75. Angell, T. (2019, March 29). Marijuana Banking Bill Approved By Congressional
Committee. Retrieved from
https://www.forbes.com/sites/tomangell/2019/03/28/marijuana-banking-bill-approved-by
-congressional-committee/#484737882ce1
76. Opioid Alternative Pilot Program. (n.d.). Retrieved from
http://www.dph.illinois.gov/topics-services/prevention-wellness/medical-cannabis/opioid
-alternative-pilot-program
77. Marotti, A. (2019, January 14). Prescribed opioids but want to try medical marijuana
instead? A new Illinois program will let you. Here's how. Retrieved from
https://www.chicagotribune.com/business/ct-biz-illinois-opioid-marijuana-program-2019
0103-story.html
78. New York State Department of Health Announces Opioid Replacement Now a
Qualifying Condition for Medical Marijuana. (n.d.). Retrieved from
https://www.health.ny.gov/press/releases/2018/2018-07-12_opioid_replacement.htm
79. Humphreys, K. (2019, February 19). Should Physicians Recommend Replacing Opioids
With Cannabis? Retrieved from
https://jamanetwork.com/journals/jama/fullarticle/2723649
80. Campbell, G. (2018, July 02). Effect of cannabis use in people with chronic non-cancer
pain prescribed opioids: Findings from a 4-year prospective cohort study. Retrieved from
https://www.sciencedirect.com/science/article/pii/S2468266718301105
81. Bachhuber, M. A. (2014, October 01). Medical Cannabis Laws and Opioid Mortality.
Retrieved from
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/1898878?resultClick=
1
82. $44.6 Billion E-Cigarette Market - Global Size, Share, Development, Growth, and
Demand Forecast, 2013-2018 & 2023 - ResearchAndMarkets.com. (2018, October 22).
Retrieved from https://www.apnews.com/edd5303cfba34fa9b4801ef49929acf5
83. Nedelman, M. (2018, November 15). Teen vaping up 80%; FDA proposes new rules.
Retrieved from
https://www.cnn.com/2018/11/15/health/fda-vaping-ecigarette-regulation/index.html
84. LaVito, A. (2018, September 12). FDA puts e-cig makers on notice: Fix 'epidemic' teen
use or products may be pulled from market. Retrieved from

46

https://www.cnbc.com/2018/09/12/teen-e-cigarette-use-product-flavors-come-under-regu
latory-scrutiny.html
85. Harris, Z. (2018, July 27). Vape Company Fails Pesticide Test, Issues First Product
Recall in Legal Market. Retrieved from
https://merryjane.com/news/vape-cartridge-company-fails-pesticide-test-becomes-first-to
-issue-product-recall-in-ca-legal-market
86. Alzghari, S. K., Fung, V., Rickner, S. S., Chacko, L., & Fleming, S. W. (2017, September
11). To Dab or Not to Dab: Rising Concerns Regarding the Toxicity of Cannabis
Concentrates. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679763/
87. Schroyer, J. (2018, December 06). Falsified California testing lab data may result in
major marijuana product recall. Retrieved from
https://mjbizdaily.com/falsified-california-testing-lab-data-may-result-in-major-marijuan
a-product-recall/
88. Luery, M. (2018, December 05). Sacramento marijuana testing lab admits to falsifying
pesticide results. Retrieved from
https://www.kcra.com/article/sacramento-marijuana-testing-lab-admits-to-falsifying-pesti
cide-results/25402844
89. Downs, D. (2019, January 29). California Cannabis Labs Are Finding Toxic Metal in
Vape Carts. Retrieved from
https://www.leafly.com/news/health/california-cannabis-labs-are-finding-toxic-metal-in-v
ape-carts
90. McDonell-Parry, A. (2018, December 06). Counterfeit Weed Vape Cartridges Are
Flooding Black Markets. Retrieved from
https://www.rollingstone.com/culture/culture-news/weed-pot-vape-counterfit-unsafe-blac
k-market-763619/
91. Mario Cartridge Packaging. (n.d.). Retrieved from
https://www.alibaba.com/product-detail/New-Arrival-Mario-Carts-Gold-Oil_6082777240
6.html
92. Mario Carts Vape Cartridge Review – Tasty, But Are They Legit? (2019, January 16).
Retrieved from https://dabconnection.com/reviews/cartridges/mario-carts-vape/
93. Exotic Cartridge Packaging. (n.d.). Retrieved from
https://www.alibaba.com/product-detail/Sundayvape-Popular-exotic-cart-pack-various_6
0859597642.html?spm=a2700.7724838.2017115.23.3bc04d52rSVDZl&s=p
94. Cigna on Medical Marijuana. (n.d.). Retrieved from
https://www.cigna.com/individuals-families/health-wellness/hw/medical-topics/medicalmarijuana-abl2153
95. Medicare Coverage of Medical Marijuana. (2019, February 13). Retrieved from
https://www.ehealthmedicare.com/medicare-coverage-articles/does-medicare-cover-medi
cal-marijuana/
47

96. Tierney, A. (2018, February 15). Canadian Health Insurance Company to Cover Medical
Cannabis. Retrieved from
https://www.vice.com/en_ca/article/neq3n8/canadian-health-insurance-company-to-cover
-medical-cannabis
97. Sherrard, M. (n.d.). How Much "Weed" Cards Cost in Every State. Retrieved from
https://www.civilized.life/articles/how-much-weed-cards-cost-in-every-state/
98. Keeler, J. (2018, September 07). Purchasing Limits in Recreational States. Retrieved
from https://www.wikileaf.com/thestash/purchasing-limits-recreational-states/
99. NorthWest Cannabis Club Basement. (n.d.). Retrieved from
https://images.potguide.com/sociallounge/453692/CmRaAAAAXgtDdMBjn7fm8SoGW
1_64EjDREdK.jpg
100. Cannabis Concentrates Breakdown. (n.d.). Retrieved from
https://coloradocannabistours.com/wp-content/uploads/2018/11/cannabis-concentrates-oil
s.jpg
101. CBD only Cannabis. (n.d.). Retrieved from
https://www.highandpolite.co.uk/wp-content/uploads/2018/10/44661635_683796282007
321_1760842480036610048_n-e1540241681563-735x400.jpg
102. Mario Cartridge Packaging. (n.d.). Retrieved from
https://www.dhgate.com/product/dhl-exotic-carts-mario-carts-package-with/432571134.h
tml
103. Exotic Cartridge Packaging. (n.d.). Retrieved from
https://www.amazon.com/All-10-Flavors-Packaging-PACKAGING/dp/B07L4Y67F8
104. Impaired Driving: Get the Facts | Motor Vehicle Safety | CDC Injury Center. (n.d.).
Retrieved from
https://www.cdc.gov/motorvehiclesafety/impaired_driving/impaired-drv_factsheet.html
105. Mercer, S. L., Sleet, D. A., Elder, R. W., Cole, K. H., Shults, R. A., & Nichols, J. L.
(2010). Translating Evidence into Policy: Lessons Learned from the Case of Lowering
the Legal Blood Alcohol Limit for Drivers. Annals of Epidemiology,20(6), 412-420.
doi:10.1016/j.annepidem.2010.03.005
106. Rense, S. (2019, February 05). Psilocybin-A.K.A. Shrooms-Could Become the Next
Legalized Drug. Retrieved from
https://www.esquire.com/lifestyle/health/a25794550/psilocybin-mushrooms-legalizationmedical-use/
107. CDC - Fact Sheets-Alcohol Use And Health - Alcohol. (n.d.). Retrieved from
https://www.cdc.gov/alcohol/fact-sheets/alcohol-use.htm
108. Global status report on alcohol and health 2018. (2018, September 21). Retrieved
from https://www.who.int/substance_abuse/publications/global_alcohol_report/en/

48

